You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯公吿精選(港股)︱非凡領越(00933.HK)進一步收購合共2876萬股李寧(02331.HK)股份

【今日焦點】

非凡領越(00933.HK)進一步收購合共2876萬股李寧(02331.HK)股份

非凡領越(00933.HK)公吿,於2025年6月20日至7月16日期間,收購方(公司的全資附屬公司)通過聯交所於公開市場上進一步收購合共2876萬股李寧公司股份,總代價約為4.55億港元(不含印花税及相關開支)。每股收購股份的平均價格約為15.83港元。

完成收購事項後,收購方將持有318,970,043股李寧股份(佔於本公吿日期李寧公司已發行股份總數約12.34%)。

在考慮到李寧公司股份的市價及其合理性,公司認為此收購事項乃合適的投資,同時此舉亦可加強集團的回報。

【重大事項】

天彩控股(03882.HK)附屬與JSC訂立貸款資本化協議

天工國際(00826.HK)與恒而達(300946.SZ)訂立戰略合作框架協議

中國碳中和(01372.HK):碳信用穩定幣協議完成測試

德昌電機控股(00179.HK)與上海機電成立人形機器人業務合資企業

郵儲銀行(01658.HK)擬出資100億元發起設立中郵金融資產投資

星謙發展(00640.HK)擬在新交所凱利板雙重主要上市

METASPACEX(01796.HK)正與壹點數智就合作事項進行積極討論

【財報業績】

德昌電機控股(00179.HK)第一財季營業額9.15億美元 同比下跌2%

金邦達寶嘉(03315.HK)盈警:預計上半年淨利同比減少20%-30%

自然美(00157.HK)盈喜:預期中期收入增加約72%

【運營數據】

永嘉集團(03322.HK):高級時裝零售業務第二季度整體收益增長率為–3%

金斯瑞生物科技(01548.HK):CARVYKTI截至6月30日止季度產生貿易銷售淨額約4.39億美元

【醫藥創新】

康希諾生物(06185.HK):組脊髓灰質炎疫苗在中國獲臨牀試驗批准

【增發供股】

大同集團(00544.HK)按“10並1”基準合併股份

國家聯合資源(00254.HK)建議“10合1”並股

【股權激勵】

十月稻田(09676.HK)授出總計1394萬股獎勵股份

微盟集團(02013.HK)授出386.1萬份受限制股份單位

【回購註銷】

阿里巴巴-W(09988.HK)7月15日耗資999萬美元回購69萬股

匯豐控股(00005.HK)7月15日耗資1.33億港元回購135.76萬股

渣打集團(02888.HK)7月15日耗資963.5萬英鎊回購73萬股

美的集團(00300.HK)7月16日耗資3271.74萬元回購44.8萬股A股

貝殼-W(02423.HK)7月15日耗資400萬美元回購63.7萬股

津上機牀中國(01651.HK)7月16日註銷487.9萬股購回股份

天鴿互動(01980.HK)7月16日註銷320萬股購回股份

元徵科技(02488.HK)7月16日註銷235.6萬股已回購股份

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account